Sees FY23 screening revenue $1.660B-$1.690B; Precision Oncology revenue $600M-$620M, and COVID-19 testing revenue $5M.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EXAS: